If this SPL incorporates inactivated NDCs shown through the FDA initiated compliance motion, they will be specified as a result.Other – Nausea and vomiting; headache, osteomalacia. The following adverse reactions as well as their incidence had been compiled from surveillance of A large number of hospitalized patients who been given barbiturates.R